Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of LW402 tablets in non-segmental vitiligo
CTR20261442Phase 2Active
- Sponsor
- Shanghai Changsen Pharmaceutical
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lw402 in Vitiligo, sponsored by Shanghai Changsen Pharmaceutical. Started May 2026; status: active.
02
Drugs
lw402
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20261442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261442.